Merck nears US$10 billion deal for London-based lung therapy firm Verona, FT reports
The deal values London-based Verona at about US$107 per American depository share, the report said, citing three people familiar with the matter. The reported purchase price represents a premium of about 23 per cent to Verona ADS' last close on the Nasdaq.
The deal would be Merck's largest since its US$10.8 billion buyout of Prometheus Biosciences in 2023.
News of the upcoming deal sent Verona's US-listed shares soaring about 18 per cent to US$102.8 in premarket trading.
Merck and London-based Verona did not immediately respond to Reuters requests for comment. Reuters could not immediately verify the report.
Merck has long leaned on its blockbuster cancer drug Keytruda, which generated nearly US$30 billion in sales in 2024, but faces looming patent expiries starting in 2028.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
In response, the company has ramped up deal-making to broaden its revenue base.
Verona, which is also listed in Frankfurt, rose into prominence with the approval of its inhalable, non-steroid treatment Ohtuvayre for patients with chronic obstructive pulmonary disease, a condition affecting nearly 16 million Americans. Its market capitalisation was about US$7.39 billion, according to LSEG data.
Over 96 per cent of Verona's first quarter revenue of about US$76 million came from the Ohtuvayre therapy.
Last month, FT reported that Merck held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than US$3 billion, while, in March, the US drugmaker also signed an up to US$2 billion licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals.
Merck's acquisition would fast track the international launch of the drug in countries outside the US, the FT report added.
Shares of Merck, valued at over US$204 billion as of Tuesday, are down by more than 18 per cent this year. REUTERS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNA
29 minutes ago
- CNA
WPP taps Microsoft exec Rose to rebuild ad group
LONDON :Britain's WPP named board member Cindy Rose as its new chief executive on Thursday, tasking the senior Microsoft executive with leading its recovery a day after a major profit warning showed the scale of the challenge at the ad group. Rose has been on the board since 2019 and will take over from outgoing CEO Mark Read on Sept. 1, the company said, with Read departing four months earlier than expected. Shares in the group, which fell to a 16-year low on Wednesday after it slashed its profit outlook, rose 2 per cent in early deals. Rose has spent the last nine years in senior leadership positions at Microsoft, where she rose to Chief Operating Officer, Global Enterprise after formerly being head of its UK business. Prior to that she worked at Vodafone and Virgin Media. WPP Chairman Philip Jansen said she had supported the digital transformation of large enterprises around the world - including embracing artificial intelligence to create new business models and revenue streams. "Her expertise in this landscape will be hugely valuable to WPP as the industry navigates fundamental changes and macroeconomic uncertainty," he said. Rose will take on a business reeling from the loss of some big accounts, a downturn in client spend, and fewer new business opportunities, which prompted the profit outlook cut that sent WPP shares down as much as 19 per cent on Wednesday. WPP, which lost its crown as the world's biggest ad group to France's Publicis last year, is also grappling with the transformational impact of AI, which gives clients the tools to create and manage more of their own marketing campaigns.
Straits Times
an hour ago
- Straits Times
Kazakhstan's leader tells Trump that he hopes for compromise on new U.S. tariffs
Sign up now: Get ST's newsletters delivered to your inbox ALMATY - Kazakh President Kassym-Jomart Tokayev told U.S. President Donald Trump in a letter that he was ready for constructive dialogue on trade issues after Trump slapped fresh 25% reciprocal tariffs on the Central Asian country. Trump launched a new global trade war this week, imposing higher tariff rates on a slew of countries as he continues his "America First" policies. Beginning August 1, goods exported from Kazakhstan to the United States will face a 25% reciprocal tariff. Most of the oil-rich country's exports will continue to be supplied without the new duties. Its key exports - oil, uranium, silver, ferroalloys, tantalum and titanium - are exempted from tariffs, according to the Kazakh trade ministry. Tokayev said in a letter to Trump that the country was ready to continue dialogue with the White House to reach a rational solution to trade issues. "Tokayev expressed confidence in reaching a compromise on the trade issue," the presidential press service said in a statement. The trade turnover between Kazakhstan and the U.S. in 2024 amounted to $4.2 billion, which is 4% higher than in 2023. Kazakhstan's main export commodity to the U.S. is crude oil, which accounts for 56.2% of total supplies, uranium - 16.4%, silver - 12.2%, ferroalloys - 9.5%, tantalum and products made from it - 0.89%. REUTERS Top stories Swipe. Select. Stay informed. Business S'pore to launch new grant for companies, expand support for workers amid US tariff uncertainties World Trump's ambassador nominee to Singapore Anjani Sinha has a rough day at Senate hearing Singapore Proposed new law protecting Singaporeans' genetic data to be strengthened: Ong Ye Kung Asia Dr Mahathir at 100: Still haunted by the Malay Dilemma Singapore What's next for PSP following its post-GE leadership shake-up? Singapore NDP 2025: Diamond formations, 'multi-axis' fly-past to headline parade's aerial display Multimedia 60 objects to mark SG60: Which is your favourite? Singapore HDB flats less attainable in 2024 compared with 2022: Report
Business Times
2 hours ago
- Business Times
TSMC revenue climbs 39% in latest sign of AI spending boom
[TAIPEI] Taiwan Semiconductor Manufacturing Company's (TSMC) revenue rose a better-than-anticipated 39 per cent in the June quarter, buoying expectations for a sustained post-ChatGPT boom in artificial intelligence (AI) spending. The chipmaker for Nvidia and Apple sales climbed to NT$934 billion (S$41 billion) for the three months, based on its reported monthly revenue. That beat the average analyst projection for about NT$928 billion. Investors have piled back into AI-linked companies, shaking off a funk that settled in after China's DeepSeek cast doubt on whether the likes of Meta Platforms and Google needed to spend that much money on data centres. This week, Nvidia became the first company in history to hit a US$4 trillion valuation, underscoring investors' renewed enthusiasm for companies such as TSMC, key to building the infrastructure for AI. TSMC chief executive officer Wei CC reassured shareholders in June that AI chip demand still outstripped supply, and reaffirmed an outlook for 2025 sales to grow in the mid-20 per cent range in US dollar terms. His company has pledged to spend another US$100 billion ramping up manufacturing in Arizona, in addition to an expansion in Japan, Germany and back home. As the world's largest contract chipmaker, TSMC sits at the heart of the global technology supply chain, producing cutting-edge chips for iPhones and Nvidia's AI offerings. While Nvidia is fuelling its growth, TSMC remains reliant on Apple and smartphone makers for most of its business. For 2025, investors remain wary about the impact of tariffs on the global economy and the electronics sector. The Trump administration's trade war is prompting economists to scale back their forecasts for gross domestic product growth worldwide, casting doubt over the outlook for everything from iPhone demand to computing. BLOOMBERG
